3430-15-7 Usage
Uses
Used in Pharmaceutical Industry:
2,3,5-Tribromo-6-methylpyridine is used as a building block for the synthesis of various pharmaceuticals due to its potential biological activity and diverse applications in drug development.
Used in Agrochemical Industry:
2,3,5-Tribromo-6-methylpyridine serves as an intermediate in the production of agrochemicals, contributing to the development of effective and targeted pest control solutions.
Used in Specialty Chemicals:
2,3,5-Tribromo-6-methylpyridine is utilized in the synthesis of specialty chemicals for specific applications, taking advantage of its unique structural features.
Used in Flavors and Fragrances Industry:
It is employed as an intermediate in the creation of flavors and fragrances, enhancing the sensory properties of various products.
Used in Material Science:
2,3,5-Tribromo-6-methylpyridine is used in the development of new materials across different industries, leveraging its chemical properties to create innovative and improved materials.
Check Digit Verification of cas no
The CAS Registry Mumber 3430-15-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,3 and 0 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3430-15:
(6*3)+(5*4)+(4*3)+(3*0)+(2*1)+(1*5)=57
57 % 10 = 7
So 3430-15-7 is a valid CAS Registry Number.
3430-15-7Relevant academic research and scientific papers
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
-
Page column 146, (2010/02/07)
Pharmaceutical compositions containing an FBPase inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.
Novel bisamidate phosphonate prodrugs
-
, (2008/06/13)
Novel bisamidate phosphonate prodrugs of FBPase inhibitors of the Formula IA: and their use in the treatment of diabetes and other conditions associated with elevated blood glucose.
Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
-
, (2008/06/13)
FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
